Prime Medicine (PRME) Cash & Equivalents (2021 - 2026)
Prime Medicine's Cash & Equivalents came in at $47.45 million for Q2 2026, down 11.8% from $53.8 million a year earlier and down 26.0% from the prior quarter.
Powered by 
Analysis
Prime Medicine (PRME) Cash & Equivalents (2021 - 2026) Analysis & Trends
At the end of FY2025, Prime Medicine's Cash & Equivalents was $63.03 million, down 65.5% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 11.3% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $182.48 million in FY2024 (+338.9%), $41.57 million in FY2023 (-77.8%), $187.62 million in FY2022 (+1.2%) and $185.42 million in FY2021 (+401.5%).
- The Q2 2026 figure represents the lowest quarterly Cash & Equivalents since Q4 2023.
- Year-over-year, Cash & Equivalents has declined for six consecutive quarters, with growth averaging 44.3% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2024 (growth of 338.9%), and the weakest in Q4 2023 (a decline of 77.8%).
- Business Quant data shows PRME's Cash & Equivalents at $64.11 million (Q1 2026), $63.03 million (Q4 2025) and $71.4 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Prime Medicine | 540.41 Mn | 540.41 Mn | - | 47.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 47.45 Mn |
| Mar 31, 2026 | 64.11 Mn |
| Dec 31, 2025 | 63.03 Mn |
| Sep 30, 2025 | 71.40 Mn |
| Jun 30, 2025 | 53.80 Mn |
| Mar 31, 2025 | 91.88 Mn |
| Dec 31, 2024 | 182.48 Mn |
| Sep 30, 2024 | 117.98 Mn |
| Jun 30, 2024 | 55.60 Mn |
| Mar 31, 2024 | 94.16 Mn |
| Dec 31, 2023 | 41.57 Mn |
| Sep 30, 2023 | 43.96 Mn |
| Jun 30, 2023 | 120.58 Mn |
| Mar 31, 2023 | 133.46 Mn |
| Dec 31, 2022 | 187.62 Mn |
| Sep 30, 2022 | 47.95 Mn |
| Jun 30, 2022 | 92.24 Mn |
| Mar 31, 2022 | 164.25 Mn |
| Dec 31, 2021 | 185.42 Mn |
| Sep 30, 2021 | 200.66 Mn |
API Access
Prime Medicine Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRME&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "PRME", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=PRME&period=max&api_key=YOUR_API_KEY");
const data = await res.json();